- Home
- BALY.T
BALY.T
BALLYS CORPORATION
Stocks
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 5.1K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -15.46 | EPS Growth: | N/A |
| 52 Week Low/High: | $16.04 - $23.20 | Next Earning Date: | 02-21-2025 |
| Revenue: | $2,481,783,000 | Revenue Growth: | 2.80% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest BALLYS CORPORATION News
BALY.T Breaking Stock News: Dive into BALY.T Ticker-Specific Updates for Smart Investing
Digital Trends
9 hours ago
5 years ago, this sci-fi Alien ripoff drowned at the box office. Is it worthy of reappraisal?
GuruFocus.com
9 hours ago
Pricesmart Inc (PSMT) Q1 2025 Earnings Call Highlights: Strong Sales Growth Amid Currency Challenges
GlobeNewswire
9 hours ago
NFWF Announces Record $7.7 Million in Grants Awarded through the Southeast Aquatics Fund Benefiting Freshwater Species
GlobeNewswire
9 hours ago
Baylor Genetics to Integrate with Epic Aura to Enhance Efficiency and Deliver Genetic Testing Results to Hospitals and Health Systems
GlobeNewswire
9 hours ago
SuperDial acquires MajorBoost to expand voice AI capabilities for US healthcare organizations
GlobeNewswire
9 hours ago
InveniAI Announces Launch of AlphaMeld Corporation and Major Milestone Updates to Reflect Cutting-Edge Innovation in AI-Driven Drug Discovery
GlobeNewswire
9 hours ago
Freddie Mac Reminds Homeowners Impacted by Devastating Wildfires in the Los Angeles Area of Mortgage Relief Options
GlobeNewswire
9 hours ago
Incubate Survey Finds That Drug Price Controls Create Headwinds for Life Sciences Startups
Share on Social Networks:
Disclaimer
The information presented on this page, "BALY.T BALLYS CORPORATION - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.